Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy
Journal of Gastroenterology, 06/08/2012Kondo Y et al.
The immunological responses of the HBV–high/HCV–high patient were low in comparison to the responses in HBV and HCV monoinfected patients. Moreover, the response of immune cells in the HBV–high/HCV–high patient during pegylated interferon/ribavirin (Peg–IFN/RBV) therapy was insufficient to suppress hepatitis B virus and hepatitis C virus (HBV/HCV).
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.